Abstract
In Drosophila, Sprouty was originally identified as an antagonist of tracheal branching and shown to be a general inhibitor of receptor tyrosine kinase. Recently, four mammalian homologues have been isolated. All Sprouty proteins exhibit a unique, highly conserved, cysteinerich C-terminal domain. Genetic and biochemical data indicate that Sprouty proteins antagonize receptor tyrosine kinase signaling through specific inhibition of the Ras / Raf / MAP Kinase pathway by preventing Ras activation. Expression of sprouty genes is regulated by FGF in a negative autoregulatory loop and is localized to known domains of FGF signaling in the developing embryo. Overexpression studies suggest that vertebrate sprouty genes may be important regulators of several developmental processes. In particular, sprouty may play a role during the branching morphogenesis involved in angiogenesis, or the formation of the lung and the kidney, but also during gastrulation or limb formation.
Keywords: sprouty protein, receptor tyrosine kinase, sprouty gene
Current Genomics
Title: Sprouty Proteins, A New Family of Receptor Tyrosine Kinase Inhibitors
Volume: 3 Issue: 4
Author(s): Isabelle Gross and Jonathan D. Licht
Affiliation:
Keywords: sprouty protein, receptor tyrosine kinase, sprouty gene
Abstract: In Drosophila, Sprouty was originally identified as an antagonist of tracheal branching and shown to be a general inhibitor of receptor tyrosine kinase. Recently, four mammalian homologues have been isolated. All Sprouty proteins exhibit a unique, highly conserved, cysteinerich C-terminal domain. Genetic and biochemical data indicate that Sprouty proteins antagonize receptor tyrosine kinase signaling through specific inhibition of the Ras / Raf / MAP Kinase pathway by preventing Ras activation. Expression of sprouty genes is regulated by FGF in a negative autoregulatory loop and is localized to known domains of FGF signaling in the developing embryo. Overexpression studies suggest that vertebrate sprouty genes may be important regulators of several developmental processes. In particular, sprouty may play a role during the branching morphogenesis involved in angiogenesis, or the formation of the lung and the kidney, but also during gastrulation or limb formation.
Export Options
About this article
Cite this article as:
Gross Isabelle and Licht D. Jonathan, Sprouty Proteins, A New Family of Receptor Tyrosine Kinase Inhibitors, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350408
DOI https://dx.doi.org/10.2174/1389202023350408 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rosuvastatin may have Neuroprotective Effect on Spinal Cord Ischemia Reperfusion Injury
CNS & Neurological Disorders - Drug Targets Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction
Current Pharmaceutical Design Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Cardiovascular Risk Factors, Metabolic Complications, & the Natural Course of CKD in Children
Current Hypertension Reviews From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Biological Potentials of Indian Traditional Medicine, Curcumin for Treating Human Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment
Current Cancer Therapy Reviews Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism
Current Pharmaceutical Design Perioperative/Periprocedural Effects of Statin Treatment for Patients Undergoing Vascular Surgery or Endovascular Procedures: An Update
Current Vascular Pharmacology Extrahepatic Targets and Cellular Reactivity of Drug Metabolites
Current Medicinal Chemistry Editorial: Protein Kinases and their Inhibitors
Current Enzyme Inhibition HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Stereoselectivity in Drug Metabolism: Molecular Mechanisms and Analytical Methods
Current Drug Metabolism Medicinal Plants with Multiple Effects on Cardiovascular Diseases: A Systematic Review
Current Pharmaceutical Design Nitric Oxide and Oral Diseases: Can We Talk About It?
Cardiovascular & Hematological Agents in Medicinal Chemistry Non-transfusion Dependent Thalassemias: A Developing Country Perspective
Current Pediatric Reviews Rewiring the Heart: Stem Cell Therapy to Restore Normal Cardiac Excitability and Conduction
Current Stem Cell Research & Therapy Chemistry and Pharmacological Properties of Some Natural and Synthetic Antioxidants for Heavy Metal Toxicity
Current Medicinal Chemistry SUBJECT INDEX TO VOLUME 1
Current Drug Safety